343 related articles for article (PubMed ID: 19289631)
21. Infratentorial ependymomas: prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients.
Guyotat J; Metellus P; Giorgi R; Barrie M; Jouvet A; Fevre-Montange M; Chinot O; Durand A; Figarella-Branger D
Acta Neurochir (Wien); 2009 Aug; 151(8):947-60. PubMed ID: 19499166
[TBL] [Abstract][Full Text] [Related]
22. Pediatric ependymoma: biological perspectives.
Kilday JP; Rahman R; Dyer S; Ridley L; Lowe J; Coyle B; Grundy R
Mol Cancer Res; 2009 Jun; 7(6):765-86. PubMed ID: 19531565
[TBL] [Abstract][Full Text] [Related]
23. Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma.
Reardon DA; Entrekin RE; Sublett J; Ragsdale S; Li H; Boyett J; Kepner JL; Look AT
Genes Chromosomes Cancer; 1999 Mar; 24(3):230-7. PubMed ID: 10451703
[TBL] [Abstract][Full Text] [Related]
24. Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma.
Tabori U; Ma J; Carter M; Zielenska M; Rutka J; Bouffet E; Bartels U; Malkin D; Hawkins C
J Clin Oncol; 2006 Apr; 24(10):1522-8. PubMed ID: 16575002
[TBL] [Abstract][Full Text] [Related]
25. Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3.
Suarez-Merino B; Hubank M; Revesz T; Harkness W; Hayward R; Thompson D; Darling JL; Thomas DG; Warr TJ
Neuro Oncol; 2005 Jan; 7(1):20-31. PubMed ID: 15701279
[TBL] [Abstract][Full Text] [Related]
26. Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.
Gojo J; Lötsch D; Spiegl-Kreinecker S; Pajtler KW; Neumayer K; Korbel P; Araki A; Brandstetter A; Mohr T; Hovestadt V; Chavez L; Kirchhofer D; Ricken G; Stefanits H; Korshunov A; Pfister SM; Dieckmann K; Azizi AA; Czech T; Filipits M; Kool M; Peyrl A; Slavc I; Berger W; Haberler C
Neuro Oncol; 2017 Sep; 19(9):1183-1194. PubMed ID: 28371821
[TBL] [Abstract][Full Text] [Related]
27. KIAA0510, the 3'-untranslated region of the tenascin-R gene, and tenascin-R are overexpressed in pilocytic astrocytomas.
El Ayachi I; Baeza N; Fernandez C; Colin C; Scavarda D; Pesheva P; Figarella-Branger D
Neuropathol Appl Neurobiol; 2010 Aug; 36(5):399-410. PubMed ID: 20202125
[TBL] [Abstract][Full Text] [Related]
28. Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups.
Dyer S; Prebble E; Davison V; Davies P; Ramani P; Ellison D; Grundy R
Am J Pathol; 2002 Dec; 161(6):2133-41. PubMed ID: 12466129
[TBL] [Abstract][Full Text] [Related]
29. Multiple chromosomal monosomies are characteristic of giant cell ependymoma.
Dahlback HS; Brandal P; Krossnes BK; Fric R; Meling TR; Meza-Zepeda LA; Danielsen HE; Heim S
Hum Pathol; 2011 Dec; 42(12):2042-6. PubMed ID: 21683982
[TBL] [Abstract][Full Text] [Related]
30. Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH.
Jeuken JW; Sprenger SH; Gilhuis J; Teepen HL; Grotenhuis AJ; Wesseling P
J Pathol; 2002 Jun; 197(2):238-44. PubMed ID: 12015749
[TBL] [Abstract][Full Text] [Related]
31. Chromosomal imbalances in clear cell ependymomas.
Rickert CH; Korshunov A; Paulus W
Mod Pathol; 2006 Jul; 19(7):958-62. PubMed ID: 16648869
[TBL] [Abstract][Full Text] [Related]
32. Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.
Godfraind C; Kaczmarska JM; Kocak M; Dalton J; Wright KD; Sanford RA; Boop FA; Gajjar A; Merchant TE; Ellison DW
Acta Neuropathol; 2012 Aug; 124(2):247-57. PubMed ID: 22526017
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity on chromosome 22 in human ependymomas.
Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
[TBL] [Abstract][Full Text] [Related]
34. Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas.
Monoranu CM; Huang B; Zangen IL; Rutkowski S; Vince GH; Gerber NU; Puppe B; Roggendorf W
Cancer Genet Cytogenet; 2008 Apr; 182(1):18-26. PubMed ID: 18328946
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma.
Friedrich C; von Bueren AO; Kolevatova L; Bernreuther C; Grob T; Sepulveda-Falla D; van den Boom L; Westphal M; Simon R; Glatzel M
Childs Nerv Syst; 2016 Feb; 32(2):281-90. PubMed ID: 26686534
[TBL] [Abstract][Full Text] [Related]
36. Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.
Lukashova-v Zangen I; Kneitz S; Monoranu CM; Rutkowski S; Hinkes B; Vince GH; Huang B; Roggendorf W
Acta Neuropathol; 2007 Mar; 113(3):325-37. PubMed ID: 17265049
[TBL] [Abstract][Full Text] [Related]
37. Pediatric ependymomas: will molecular biology change patient management?
Grill J; Bergthold G; Ferreira C
Curr Opin Oncol; 2011 Nov; 23(6):638-42. PubMed ID: 21892086
[TBL] [Abstract][Full Text] [Related]
38. Distribution of the extracellular matrix glycoproteins in ependymomas--an immunohistochemical study with follow-up analysis.
Zámecník J; Chánová M; Tichý M; Kodet R
Neoplasma; 2004; 51(3):214-22. PubMed ID: 15254676
[TBL] [Abstract][Full Text] [Related]
39. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.
Rousseau A; Idbaih A; Ducray F; Crinière E; Fèvre-Montange M; Jouvet A; Delattre JY
J Neurooncol; 2010 May; 97(3):353-64. PubMed ID: 19865800
[TBL] [Abstract][Full Text] [Related]
40. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]